Telix Net Income from 2010 to 2026

TLX Stock   7.05  0.20  2.76%   
Telix Pharmaceuticals Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -11.2 M in 2026. During the period from 2010 to 2026, Telix Pharmaceuticals Net Loss regression line of annual values had r-squared of  0.04 and arithmetic mean of (14,524,111). View All Fundamentals
 
Net Loss  
First Reported
2000-09-30
Previous Quarter
-3.5 M
Current Value
-7.3 M
Quarterly Volatility
17 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Other Operating Expenses of 1.2 B, Operating Income of 28 M or EBITDA of 83.8 M, as well as many indicators such as Price To Sales Ratio of 2.88, Dividend Yield of 0.53 or PTB Ratio of 5.77. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Telix Stock
Check out the analysis of Telix Pharmaceuticals Correlation against competitors.
The evolution of Net Income for Telix Pharmaceuticals Limited provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Telix Pharmaceuticals compares to historical norms and industry peers.

Latest Telix Pharmaceuticals' Net Income Growth Pattern

Below is the plot of the Net Income of Telix Pharmaceuticals Limited over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Telix Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Telix Pharmaceuticals Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Telix Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (10.69 M)10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

Telix Net Income Regression Statistics

Arithmetic Mean(14,524,111)
Geometric Mean5,527,498
Coefficient Of Variation(240.73)
Mean Deviation23,440,771
Median(2,544,034)
Standard Deviation34,963,603
Sample Variance1222.5T
Range154M
R-Value(0.21)
Mean Square Error1248.7T
R-Squared0.04
Significance0.43
Slope(1,425,656)
Total Sum of Squares19559.3T

Telix Net Income History

2026-11.2 M
2025-10.7 M
202449.9 M
20235.2 M
2022-104.1 M
2021-80.5 M
2020-44.9 M

Other Fundumenentals of Telix Pharmaceuticals

Telix Pharmaceuticals Net Income component correlations

About Telix Pharmaceuticals Financial Statements

Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-10.7 M-11.2 M
Net Loss-7.1 M-7.5 M
Net Loss(0.03)(0.03)
Net Income Per E B T 1.35  0.81 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.